The Monsanto acetic acid procedure is a carbonylation reaction utilising an organometallic catalyst. It was first created by Monsanto in the 1970s with the purpose of producing acetic acid commercially from methanol. Dual catalysis is used in the process, utilising HI and [RhI 2 (CO) 2]-as a co-catalyst. Early in the 1950s, German scientist Karl Ziegler developed a process for producing nearly fully linear HDPE at low pressures and low temperatures in the presence of intricate organometallic catalysts. Heterogeneous catalysts or organometallic catalysts, like palladium on carbon. These phrases are employed because the homogeneous type of reaction, in which catalysis occurs at the catalyst's surface, occurs with the catalyst and reaction substrates being in the same phase but not in the heterogeneous type.
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via design-driven bio- and chemical engineering view of biotech
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Application of metal single-site zeolite catalysts in heterogeneous catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Use of iron nanomaterials for the treatment of metals, metalloids and emergent contaminants in water
Marta I Litter, University of General San Martin, Argentina
Title : One-pot multicomponent syntheses of functional chromophores – Synthetic efficiency meets functionality design
Thomas J J Muller, Heinrich-Heine-Universitat Dusseldorf, Germany
Title : From photocatalysis to photon-phonon co-driven catalysis for inert molecules activation
Junwang Tang, Tsinghua University, China
Title : Antibody-proteases as a generation of unique biomarkers, potential targets and translational tools towards design-driven bio- and chemical engineering and personalized and precision medical practice
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico